Wednesday, June 06, 2018 5:12:40 PM
"She probably is a bit preoccupied with her demanding job at IPIX."
She's been at IPIX for over a year and a half and hasn't had time to identify that she is employed by the company as Vice President, Clinical Sciences and Portfolio Management on her LinkedIn page, instead indicating that during the exact same period she has simply been a Clinical Research & Project Management Consultant in the Greater Boston Area?
Her name doesn't come up often, but it did earlier today when this quote appeared from an October 2016 PR entitled "Cellceutix Begins Phase 2b Clinical Trial of Oral Prurisol in Moderate-to-Severe Chronic Plaque Psoriasis":
“We look forward to efficient execution of this important trial for our psoriasis program. Having partnered with one of the premier CROs in the Dermatology therapy area for this study, I am confident that we will be able to assess interim and final study results in a timely fashion,” said Jane Harness, Cellceutix VP, Clinical Sciences and Portfolio Management." (highlight mine)
I probably don't have to tell you that that trial and the lack of access to results 1)at all and/or 2)on a timely basis has been Topic A on the board lately.
Obviously the Company includes her on its Senior Management page so there would seem to be no question about her ongoing employment, but her choice to not identify herself that way on her LinkedIn page...and the way she DOES identify herself...seems to me to be fairly described as "odd".
As a footnote, Ms Harness and Dr Bertolino both came to IPIX from prior engagements at Revance. Ironically that connection is missing from the Senior Management page coverage of Dr Bertolino's background. Maybe that is something worth looking into, especially given the current context of a canceled interim and overdue "final" study result that were expected with some confidence to occur on a timely basis.
https://www.linkedin.com/in/janeharness/
http://www.ipharminc.com/senior-management/
But can it core A apple?
Yes Ralph, of course it can core A apple.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM